Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

F Wu, J Yang, J Liu, Y Wang, J Mu, Q Zeng… - … and Targeted Therapy, 2021 - nature.com
To flourish, cancers greatly depend on their surrounding tumor microenvironment (TME),
and cancer-associated fibroblasts (CAFs) in TME are critical for cancer occurrence and …

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma

A Elmusrati, J Wang, CY Wang - International journal of oral science, 2021 - nature.com
Head and neck squamous cell carcinoma (HNSCC), an aggressive malignancy, is
characterized by high morbidity and low survival rates with limited therapeutic options …

Cancer-associated fibroblasts: how do they contribute to metastasis?

MQ Kwa, KM Herum, C Brakebusch - Clinical & experimental metastasis, 2019 - Springer
Cancer-associated fibroblasts (CAFs) are activated fibroblasts in the tumor
microenvironment. They are one of the most prominent cell types in the stroma and produce …

Targeting oral tumor microenvironment for effective therapy

HS Budi, B Farhood - Cancer Cell International, 2023 - Springer
Oral cancers are among the common head and neck malignancies. Different anticancer
therapy modalities such as chemotherapy, immunotherapy, radiation therapy, and also …

Inflammatory mediators in oral cancer: pathogenic mechanisms and diagnostic potential

SE Niklander - Frontiers in Oral Health, 2021 - frontiersin.org
Approximately 15% of cancers are attributable to the inflammatory process, and growing
evidence supports an association between oral squamous cell carcinoma (OSCC) and …

Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway

Y Wang, Y Jing, L Ding, X Zhang, Y Song… - Journal of Experimental …, 2019 - Springer
Background Local resident normal fibroblasts (NFs) are the major source of cancer-
associated fibroblasts (CAFs), which are distinguishable from NFs by their tumor-supportive …

Cancer-associated fibroblasts in oral cancer: a current perspective on function and potential for therapeutic targeting

KJ Bienkowska, CJ Hanley, GJ Thomas - Frontiers in Oral Health, 2021 - frontiersin.org
The role of the tumour microenvironement (TME) in cancer progression and resistance to
therapies is now widely recognized. The most prominent non-immune cell type in the …

Ovatodiolide suppresses oral cancer malignancy by down-regulating exosomal Mir-21/STAT3/β-catenin cargo and preventing oncogenic transformation of normal …

JH Chen, ATH Wu, OA Bamodu, VK Yadav, TY Chao… - Cancers, 2019 - mdpi.com
Oral squamous cell carcinoma (OSCC) is among the most commonly diagnosed
malignancies in the world. Patients with OSCC often develop treatment resistance, resulting …

Fucoidan/hyaluronic acid cross-linked zein nanoparticles loaded with fisetin as a novel targeted nanotherapy for oral cancer

MA Moustafa, WM El-Refaie, YSR Elnaggar… - International Journal of …, 2023 - Elsevier
Fisetin (FS) is an anticancer drug having potential role in oral tumors management.
However, its clinical application is limited due to its hydrophobicity and instability. Bioactive …

Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancer

M Custódio, A Biddle, M Tavassoli - Oral Oncology, 2020 - Elsevier
Complex interactions take place during cancer formation and progression. In this regard,
there has been increasing focus on the non-malignant cells that make up the tumour …